New Zealand markets open in 8 hours 20 minutes


NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
79.56+0.86 (+1.09%)
As of 09:40AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 45.93B
Enterprise value 67.36B
Trailing P/E 14.36
Forward P/E 16.16
PEG ratio (5-yr expected) 1.68
Price/sales (ttm)2.16
Price/book (mrq)2.79
Enterprise value/revenue 3.81
Enterprise value/EBITDA 13.13

Trading information

Stock price history

Beta (5Y monthly) 1.62
52-week change 318.51%
S&P500 52-week change 323.42%
52-week high 380.81
52-week low 355.91
50-day moving average 375.49
200-day moving average 368.84

Share statistics

Avg vol (3-month) 33.07M
Avg vol (10-day) 32.71M
Shares outstanding 5583.64M
Implied shares outstanding 6583.16M
Float 8581.08M
% held by insiders 10.18%
% held by institutions 170.11%
Shares short (28 Mar 2024) 410.58M
Short ratio (28 Mar 2024) 43.47
Short % of float (28 Mar 2024) 42.06%
Short % of shares outstanding (28 Mar 2024) 41.81%
Shares short (prior month 29 Feb 2024) 410.76M

Dividends & splits

Forward annual dividend rate 43.96
Forward annual dividend yield 45.03%
Trailing annual dividend rate 33.86
Trailing annual dividend yield 34.90%
5-year average dividend yield 47.04
Payout ratio 469.71%
Dividend date 314 Feb 2024
Ex-dividend date 429 Jan 2024
Last split factor 211422:10000
Last split date 303 Feb 2014

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin 15.04%
Operating margin (ttm)21.47%

Management effectiveness

Return on assets (ttm)6.28%
Return on equity (ttm)23.14%

Income statement

Revenue (ttm)17.68B
Revenue per share (ttm)36.50
Quarterly revenue growth (yoy)4.00%
Gross profit (ttm)N/A
Net income avi to common (ttm)2.66B
Diluted EPS (ttm)5.48
Quarterly earnings growth (yoy)41.90%

Balance sheet

Total cash (mrq)338M
Total cash per share (mrq)0.58
Total debt (mrq)21.76B
Total debt/equity (mrq)132.03%
Current ratio (mrq)0.90
Book value per share (mrq)28.27

Cash flow statement

Operating cash flow (ttm)4.42B
Levered free cash flow (ttm)1.23B